Key terms
About ISPC
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Lexington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ISPC news
Mar 26
4:23pm ET
iSpecimen Appoints Elizabeth Graham as New Class III Director
Mar 14
9:23am ET
iSpecimen Discusses FY2023 Results, Offers Replay Access
Mar 08
8:46am ET
Craig-Hallum Releases a Buy Rating on iSpecimen (ISPC)
Feb 16
9:05am ET
Craig-Hallum Remains a Buy on iSpecimen (ISPC)
Feb 15
5:24pm ET
iSpecimen Terminates Warrants and Concludes Obligations
Jan 23
8:45am ET
Craig-Hallum Sticks to Its Buy Rating for iSpecimen (ISPC)
Jan 23
7:35am ET
iSpecimen, TriMetis Life announces strategic partnership
No recent news articles are available for ISPC
ISPC Financials
Key terms
Ad Feedback
ISPC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ISPC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range